Eculizumab is an effective treatment for patients with atypical hemolytic syndrome (aHUS) receiving chronic plasma therapy (PT)

  1. Lookup NU author(s)
  2. Professor Tim Goodship
Author(s)Goodship TH, Muus P, Legendre CM, Douglas K, Hourmant M, Delmas Y, Herthelius BM, Trivelli A, Loirat C, Bedrosian C, Licht C
Publication type Conference Proceedings (inc. Abstract)
Conference NameBritish Journal of Haematology: 51st Annual Scientific Meeting of the British Society for Haematology
Conference LocationBrighton, UK
Year of Conference2011
Source Publication Date4-6 April 2011
Volume153 (s1)
Pages24 abstract no. 49
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
PublisherWiley-Blackwell Publishing Ltd.
Actions    Link to this publication
Library holdingsSearch Newcastle University Library for this item